Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-17 Purchase | 2024-12-18 08:27 am | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chairman and Chief Scientist 10% Owner | 40,000 | $1.17 | $46,800 | 1,516,834 (Indirect Direct) | View |
| 2023-08-23 Purchase | 2023-08-24 12:14 pm | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner | 100,000 | $0.33 | $33,000 | 14,768,329 (Indirect Direct) | View |
| 2023-08-22 Purchase | 2023-08-23 09:24 am | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner | 200,000 | $0.322 | $64,400 | 14,668,329 (Indirect Direct) | View |
| 2022-12-07 Sale | 2022-12-09 4:33 pm | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Director 10% Owner | 400,000 | $1 | $400,000 | 14,468,329 (Indirect Direct) | View |
| 2022-06-01 Purchase(A) | 2022-06-02 09:46 am | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner | 100,000 | $0.58 | $58,000 | 14,868,329 (Indirect Direct) | View |
| 2022-06-01 Purchase | 2022-06-02 08:55 am | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner | 100,000 | $58 | $5,800,000 | 14,868,329 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-14 Ownership | 2023-02-14 5:14 pm | N/A N/A | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Director 10% Owner | 300,000 | $0 | 14,468,329 (Indirect) | View |
| 2021-05-24 Option Award | 2021-06-10 6:48 pm | N/A N/A | NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Executive Officer 10% Owner | 14,817,329 | $0 | 1,468,332 (Direct) | View |